Indicated for: depression; obsessive-compulsive disorder
Route of administration: oral
Substance: clomipramine (antidepressant)
ATC: N06AA04 (Nervous system | Antidepressants | Non-selective monoamine reuptake inhibitors)
Clomipramine is a tricyclic antidepressant (TCA) primarily used to treat obsessive-compulsive disorder (OCD). It is also indicated for the treatment of major depression, panic attacks, phobias, anxiety disorders, and, in some cases, chronic pain or nocturnal enuresis in children.
Clomipramine works by increasing the levels of serotonin and norepinephrine in the brain by inhibiting their reuptake. This mechanism helps regulate mood and reduce symptoms of anxiety and obsessions. Therapeutic effects may take 2-4 weeks to become noticeable.
While effective, clomipramine can cause side effects. The most common include dry mouth, constipation, drowsiness, dizziness, weight gain, and excessive sweating. In rare cases, it may cause more serious effects, such as cardiac arrhythmias, seizures, or manic symptoms. Patients should be monitored for signs of worsening depression or suicidal thoughts, especially at the beginning of treatment.
Clomipramine should be used as directed by a doctor, and the dosage should be gradually adjusted to minimize the risk of side effects. Alcohol consumption is contraindicated during treatment, as it may enhance sedative effects. Concurrent use with monoamine oxidase inhibitors (MAOIs) should also be avoided due to the risk of severe reactions. If severe side effects or unusual symptoms occur, immediate medical attention is necessary.